HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas LaRocca Selected Research

BnSO(2)-D-Arg-Gly-Arg-ketothiazole

11/2003Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas LaRocca Research Topics

Disease

2Thrombosis (Thrombus)
11/2003 - 08/2003
1Inflammation (Inflammations)
01/2018
1Ischemia
01/2018

Drug/Important Bio-Agent (IBA)

2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2003 - 08/2003
1Proteins (Proteins, Gene)FDA Link
01/2018
1Chemotactic FactorsIBA
01/2018
1CytokinesIBA
01/2018
1ChemokinesIBA
01/2018
1Collagen Type III (Type III Collagen)IBA
11/2003
1phenylalanyl- prolyl- arginine- chloromethyl ketone (PPACK)IBA
11/2003
1BnSO(2)-D-Arg-Gly-Arg-ketothiazoleIBA
11/2003
1CT 50547IBA
11/2003
1AnticoagulantsIBA
11/2003
1Heparin (Liquaemin)FDA LinkGeneric
11/2003
1ThrombinFDA Link
11/2003
1A-factor (Streptomyces)IBA
11/2003